CONCORD

Concord Drugs Ltd, incorporated in 1995, operates in the pharmaceutical industry in India. The company manufactures licensed drugs based on approved formulations and specializes in developing and producing drug delivery systems such as the Multiple Unit Pellet System (MUPS), sustained release, and modified release pellets. It provides contract manufacturing services covering the process from drug development to finished pharmaceutical formulations. Concord Drugs Ltd operates a WHO-GMP certified facility and focuses primarily on the pharmaceutical formulation segment. There are no public listings or subsidiaries associated with the company according to available information.